287 related articles for article (PubMed ID: 3081705)
1. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
Galloway MP; Wolf ME; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
[TBL] [Abstract][Full Text] [Related]
2. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
Wolf ME; Galloway MP; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
[TBL] [Abstract][Full Text] [Related]
3. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
4. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
[TBL] [Abstract][Full Text] [Related]
5. Regulation of dopamine and serotonin synthesis by acute administration of cocaine.
Galloway MP
Synapse; 1990; 6(1):63-72. PubMed ID: 2119072
[TBL] [Abstract][Full Text] [Related]
6. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
Claustre Y; Fage D; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
8. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
[TBL] [Abstract][Full Text] [Related]
9. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
10. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
Kilts CD; Anderson CM; Ely TD; Nishita JK
J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
12. Evidence for dopamine autoreceptors in mesocortical dopamine neurons.
Fadda F; Gessa GL; Marcou M; Mosca E; Rossetti Z
Brain Res; 1984 Feb; 293(1):67-72. PubMed ID: 6423212
[TBL] [Abstract][Full Text] [Related]
13. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
14. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
Bean AJ; Shepard PD; Bunney BS; Nestler EJ; Roth RH
Mol Pharmacol; 1988 Dec; 34(6):715-8. PubMed ID: 2974120
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of mesocortical dopamine neurons.
Bannon MJ; Roth RH
Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
[TBL] [Abstract][Full Text] [Related]
16. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
17. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
18. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
Matthews RT; McMillen BA; Sallis R; Blair D
J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
[TBL] [Abstract][Full Text] [Related]
19. Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction.
Nowak JZ
Pol J Pharmacol Pharm; 1985; 37(3):359-81. PubMed ID: 2866503
[TBL] [Abstract][Full Text] [Related]
20. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
Hársing LG; Vizi ES
Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
